Total Payments
$3,095
2023 Payments
$28.09
Companies
23
Transactions
205
Medicare Patients
1,456
Medicare Billing
$87,865
Payment Breakdown by Category
Food & Beverage$3,055 (98.7%)
Education$39.53 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,055 | 200 | 98.7% |
| Education | $39.53 | 5 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,017 | 56 | $0 (2023) |
| Lilly USA, LLC | $440.69 | 32 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $391.06 | 28 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $316.10 | 30 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $142.52 | 9 | $0 (2023) |
| PFIZER INC. | $97.84 | 7 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $88.65 | 6 | $0 (2022) |
| ABBVIE INC. | $88.54 | 5 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $71.91 | 5 | $0 (2019) |
| Shire North American Group Inc | $71.37 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.09 | 2 | Novo Nordisk Inc ($14.68) |
| 2022 | $510.09 | 26 | Novo Nordisk Inc ($206.43) |
| 2021 | $253.40 | 18 | Lilly USA, LLC ($80.89) |
| 2020 | $383.27 | 19 | Novo Nordisk Inc ($196.15) |
| 2019 | $460.30 | 32 | AstraZeneca Pharmaceuticals LP ($109.86) |
| 2018 | $645.41 | 44 | Novo Nordisk Inc ($186.45) |
| 2017 | $814.11 | 64 | Novo Nordisk Inc ($299.80) |
All Payment Transactions
205 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Diabetes | ||||||
| 01/11/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: DIABETES | ||||||
| 12/07/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Diabetes | ||||||
| 11/16/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: Diabetes Care | ||||||
| 11/09/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Diabetes | ||||||
| 10/19/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Neuroscience | ||||||
| 09/28/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 09/14/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Diabetes | ||||||
| 08/31/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: RESPIRATORY | ||||||
| 08/03/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Diabetes | ||||||
| 08/03/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: Diabetes | ||||||
| 07/27/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Diabetes | ||||||
| 06/22/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug), Seglentis | Food and Beverage | Cash or cash equivalent | $15.57 | General |
| Category: Cardiovascular | ||||||
| 06/09/2022 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 06/02/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 06/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: NEUROSCIENCE | ||||||
| 05/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardio-renal | ||||||
| 05/12/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Diabetes | ||||||
| 05/04/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Diabetes | ||||||
| 04/27/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: Neuroscience | ||||||
| 04/06/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: NEUROSCIENCE | ||||||
| 03/30/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 03/02/2022 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 02/24/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes | ||||||
| 02/16/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 80 | 83 | $5,835 | $731.00 |
| 2022 | 5 | 435 | 677 | $61,659 | $28,730 |
| 2021 | 4 | 454 | 720 | $66,861 | $32,853 |
| 2020 | 7 | 487 | 765 | $67,770 | $25,551 |
Total Patients
1,456
Total Services
2,245
Medicare Billing
$87,865
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 54 | $5,400 | $487.40 | 9.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 29 | $435.00 | $243.60 | 56.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 205 | 403 | $40,300 | $18,450 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 62 | 85 | $12,240 | $6,360 | 52.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 27 | 27 | $6,129 | $3,315 | 54.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 126 | 142 | $2,130 | $420.93 | 19.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 15 | 20 | $860.00 | $184.07 | 21.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 217 | 449 | $44,900 | $21,506 | 47.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 96 | $13,824 | $7,631 | 55.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 26 | 26 | $5,902 | $3,269 | 55.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 131 | 149 | $2,235 | $447.00 | 20.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 229 | 468 | $46,800 | $16,546 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 41 | 41 | $9,307 | $4,467 | 48.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 53 | $7,632 | $3,426 | 44.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 138 | 159 | $2,385 | $474.66 | 19.9% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 17 | 22 | $919.95 | $255.52 | 27.8% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 11 | 11 | $440.00 | $210.87 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $286.00 | $171.05 | 59.8% |
About Dr. Jeffrey Kellogg, MD
Dr. Jeffrey Kellogg, MD is a Adolescent Medicine healthcare provider based in Shepherdstown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2007. The National Provider Identifier (NPI) number assigned to this provider is 1861532350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Kellogg, MD has received a total of $3,095 in payments from pharmaceutical and medical device companies, with $28.09 received in 2023. These payments were reported across 205 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,055).
As a Medicare-enrolled provider, Kellogg has provided services to 1,456 Medicare beneficiaries, totaling 2,245 services with total Medicare billing of $87,865. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Adolescent Medicine
- Other Specialties Adult Medicine, Geriatric Medicine
- Location Shepherdstown, WV
- Active Since 02/07/2007
- Last Updated 05/15/2013
- Taxonomy Code 207QA0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861532350
Products in Payments
- Ozempic (Drug) $499.21
- FARXIGA (Drug) $352.74
- Victoza (Drug) $224.03
- JARDIANCE (Drug) $196.99
- TRULICITY (Drug) $189.85
- INVOKANA (Drug) $165.80
- XARELTO (Drug) $127.90
- RYBELSUS (Drug) $101.85
- Trintellix (Drug) $90.41
- Livalo (Drug) $88.65
- Tresiba (Drug) $80.32
- CHANTIX (Drug) $70.03
- UBRELVY (Drug) $66.13
- TRADJENTA (Drug) $59.54
- Rybelsus (Drug) $54.12
- VRAYLAR (Drug) $51.14
- MOUNJARO (Drug) $43.21
- MYDAYIS (Drug) $38.57
- TOUJEO (Drug) $37.98
- EMGALITY (Drug) $33.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.